COVID-19
We applaud and support the efforts of teams developing treatments for COVID-19. As a proven leader in regulatory affairs, we understand the challenges that come with crucial studies. We stand ready to help those working for answers to navigate complex regulatory issues.
Slider

Service Solutions

Cato Research, Your Reliable Partner

Cato Research (CATO) is an international regulatory and clinical contract research organization (CRO) that has been delivering successful outcomes for its clients since 1988. Through highly qualified and experienced personnel located in offices across North America, Europe, Israel, and South Africa, supported by strategic alliances with selected regional CROs, CATO offers tried-and-trusted international coverage.

CATO has the advantage of integrated regulatory, clinical, and scientific expertise. Our highly talented and experienced international team offers services from preclinical through IND (or equivalent), clinical development, and marketing approval to Phase 4 postmarketing research. Our track record includes successes across many different health products, including drugs, biologics, vaccines, cell therapies (including stem cells), nutriceuticals, medical foods, devices, and diagnostics. In terms of diseases and indications, CATO has been involved in a wide variety of projects with a dominant focus in oncology, neurology/CNS, and rare and orphan drug indications. This experience includes leadership of, and involvement in some of the most challenging and innovative products.

Therapeutic Expertise

What our Sponsors say about us...

Very impressed with the quality and efficiency that Cato…

"I’m very impressed with the quality and efficiency that Cato put into the protocol. Kudos for your team. I am hoping that we will have more collaboration with you in the near future, not only for NDA, but for other technical writing projects."

- Vice President of Medical, Southeast Pharmaceutical Company

Cato Research - International Contract Research Organization | Research Triangle Park, Durham, North Carolina
2019-11-08T15:45:27-05:00

- Vice President of Medical, Southeast Pharmaceutical Company

"I’m very impressed with the quality and efficiency that Cato put into the protocol. Kudos for your team. I am hoping that we will have more collaboration with you in the near future, not only for NDA, but for other technical writing projects."

Type C Meeting with FDA

Dear CATO team,

On behalf of the our team, I would like to thank you for your support at the Type C meeting with FDA as well as your great input and challenge at the prep meeting. We could secure the outcome that we wanted to achieve!

- VP Global Regulatory Affairs

European Pharma Company

Cato Research - International Contract Research Organization | Research Triangle Park, Durham, North Carolina
2019-12-06T10:51:16-05:00

- VP Global Regulatory Affairs

European Pharma Company

Dear CATO team, On behalf of the our team, I would like to thank you for your support at the Type C meeting with FDA as well as your great input and challenge at the prep meeting. We could secure the outcome that we wanted to achieve!
0
0
Cato Research - International Contract Research Organization | Research Triangle Park, Durham, North Carolina

Upcoming Events

No event found!
Load More

Cato Research Blog

  • New FDA Gudiances for February 2020 and Upcoming...
    by Cato Research on March 4, 2020 at 6:28 pm

    By Sheila Plant, PhD, MHS, RAC, Senior Director, Regulatory Strategy, CATO SMS    Special Interest Guidances/Information Date Posted Policy for Diagnostics Testing in Laboratories Certified to Perform High Complexity Testing under CLIA prior to Emergency Use Authorization for Coronavirus […]

  • What’s New Health Canada? January and February...
    by Cato Research on March 4, 2020 at 5:52 pm

      By Alejandra Gomez Perez, M.Sc., Regulatory Affairs Associate   What’s New in:   Therapeutic Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/what-new-drug-products-health-canada.html Biologics and Genetic Therapies Directorate: […]

Twitter @CatoResearch

LinkedIn Cato Research

Facebook @catoresearch

Searching for something else?